Tonsillectomy 
Made Better

The BiZact™ device has been clinically shown to:

• Reduce intraoperative blood loss^1,††
• Improve procedural efficiency^1,([FOOTNOTE=Lee SW, Jeon SS, Lee JD, Lee JY, Kim SC, Koh YW. A comparison of postoperative pain and complications in tonsillectomy using BiClamp forceps and electrocautery tonsillectomy. Otolaryngol Head Neck Surg. 2008;139(2):228‑234.],[ANCHOR=],[LINK=])^,([FOOTNOTE=Omrani M, Barati B, Omidifar N, Okhovvat AR, Hashemi SA. Coblation™* versus traditional tonsillectomy: A double blind randomized controlled trial. J Res Med Sci. 2012;17(1):45‑50.],[ANCHOR=],[LINK=])^,‡
• Reduce the incidence of postoperative hemorrhage([FOOTNOTE=Brown, E. (2019). A prospective, multi‑center, single arm study of BiZact™ on children undergoing tonsillectomy. Data on file. Study sponsored by Medtronic. ClinicalTrials.gov Identifier: NCT03266094],[ANCHOR=],[LINK=])^,([FOOTNOTE=Francis D, Fonnesbeck C, Sathe N, McPheeters M, Krishnaswami S, Chinnadurai S. Postoperative bleeding and associated utilization following tonsillectomy in children: a systematic review and meta‑analysis. Otolaryngology Head and Neck Surgery. 2017; 156(3):442‑455.],[ANCHOR=],[LINK=])^,§

Surgeons using the BiZact™ device are completing cases in about half the time^1,4,5,†† compared to the Coblator™* device and electrocautery.  Because the BiZact™ device: 

• Offers a fast and easy setup([FOOTNOTE=Based on internal test report #RE00073873 and #RE00079704, Independent surgeon and nurse feedback collected during Medtronic sponsored labs. January and February 2017.],[ANCHOR=],[LINK=])^,₤
• In‑line activation facilitates efficient sealing and transection
• Reduces intraoperative bleeding^1-3,§§,Ω